The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpectra (di/ S) Regulatory News (SPSC)

Share Price Information for Spectra (di/ S) (SPSC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 260.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 80.00 (36.364%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 260.00
SPSC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Settlement of lawsuit and termination of agreement

20 Jun 2014 07:00

RNS Number : 1024K
Spectra Systems Corporation
20 June 2014
 

June 20, 2014

 

Spectra Systems Corporation

("The Company" or "Spectra")

Spectra Systems Settles Lawsuit and Terminates Business Agreement

Spectra has agreed to settle a lawsuit filed by one of its shareholders and business partners and terminate the related royalty agreement for sales of certain banknote authentication materials.

The suit was filed on 13 February 2013 for damages totalling $2,136,091 to cover the period from 2004 to 2010. This amount was subsequently reduced to $1,272,397 due to enforcement of the statute of limitations, which bars claims that accrued more than six years prior to the filing of the lawsuit.

The Board is pleased to have reached a settlement which terminates the agreement and liabilities that would otherwise have continued through the remaining multi-year agreement, and settles the pending litigation and avoids further significant legal costs. The settlement was reached at a cost to Spectra of approximately $2.1MM.

The settlement will result in a one-time, exceptional charge to the Company's profits in 2013 of $1.8MM after offsetting accruals already made in respect of the period from 2006 - 2012. This appears as an exceptional item expense in its statement of income and as an increase to the accrual on its balance sheet and statement of cash flow, net of an estimated tax benefit of $700,000. This exceptional charge will be accounted for in Spectra's accounts for the year ended 31 December 2013, the preliminary statement of which was released on 30 April 2014. 

It is anticipated that the Annual Report and Accounts will be circulated to shareholders of Spectra Systems Corporation on 24 June.

The Board's decision to accept this settlement was based on the legal advice that Spectra had a very high probability of success for the period from 2004 to 2013 and a likely, but less certain, probability of success for the remainder of the contract.

The amount which would have been owed, based on the highly probable outcome that we would prevail for the 2004 to 2013 period, would have been approximately $800,000. This, along with the estimated legal fees through trial of $500,000 would have resulted in a cost to Spectra of approximately $1.3MM.

The analysis for the less certain outcome relating to the future contract years based on the historical levels of authentication materials shipment before 2012 could have resulted in approximately $1.6MM of estimated contract payments for the future years remaining on the agreement and could have been much higher if the order volumes in the future years are in excess of these levels. The estimated potential cost of the base case for the future contract years, along with the successful outcome for the previous years, plus legal fees, could have resulted in $2.9MM of costs to the Company.

Based on the analysis described, the Board concluded that the settlement of approximately $2.1MM, with a termination of the agreement, is the correct business decision and will result in significant savings for Spectra.

 

Enquiries:

Spectra Systems CorporationDr. Nabil Lawandy, Chief Executive Officer Tel: +1 (0) 401 274 4700

WH Ireland LimitedChris Fielding (Head of Corporate Finance) Tel: +44 (0) 20 7220 1650

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGRLKLLFZQFEBBX
Date   Source Headline
27th Mar 20247:00 amRNSAudited results for 12 months ended 31 Dec 2023
11th Jan 20247:00 amRNSExercise of Options and Director/PDMR Shareholding
28th Dec 20237:00 amRNSExercise of Options
21st Dec 202312:15 pmRNSCompletion of Acquisition
15th Dec 20234:35 pmRNSExercise of Options and transfer of shares
4th Dec 20237:00 amRNSAcquisition of Cartor Holdings Limited
6th Nov 20234:43 pmRNSTR-1
12th Oct 20237:00 amRNSLargest Central Bank Consumables Order
25th Sep 20237:00 amRNSInterim Results for Six Months Ended 30 June 2023
7th Jul 20236:01 pmRNSRemoval of Regulation S restrictions from shares
26th Jun 20233:22 pmRNSAnnual General Meeting Lack of Quorum
30th May 20237:00 amRNSAppointment of Chief Financial Officer
25th Apr 20237:00 amRNSAdditional Sensor Services Contract Amendment
24th Apr 20237:00 amRNSResignation of Chief Financial Officer
19th Apr 20237:05 amRNSRemoval of Reg S restrictions from common stock
6th Apr 20237:00 amRNSExercise of Options
31st Mar 20235:14 pmRNSRemoval of Reg S restrictions from shares
21st Mar 202311:44 amRNSDividend Record Date
20th Mar 20237:00 amRNSAudited results for year ended 31 December 2022
16th Mar 20234:35 pmRNSExercise of Options
6th Mar 202310:39 amRNSRemoval of Reg S restrictions from common stock
11th Oct 20226:12 pmRNSDirector/PDMR Shareholding
3rd Oct 20227:00 amRNSContract Amendment to a Central Bank
21st Sep 20227:00 amRNSExercise of Options
12th Sep 20227:05 amRNSAppointment of Non-Executive Director
12th Sep 20227:00 amRNSInterim Results for Six Months Ended 30 June 2022
16th Aug 20227:00 amRNSFirst Banknote Disinfection System Sold
15th Aug 20227:00 amRNSNew Central Bank Contract Amendment
28th Jul 20227:00 amRNSShare Buy-Back
1st Jul 20222:31 pmRNSShare Buy-Back
28th Jun 20227:00 amRNSShare Buy-Back
15th Jun 20227:00 amRNSAdditional Central Bank Development Revenues
14th Jun 20227:00 amRNSAppointment of Chief Financial Officer
13th Jun 20227:00 amRNSAnnual General Meeting Update
25th May 20227:00 amRNSExercise of Options and Director/PDMR Shareholding
20th May 20228:44 amRNSRemoval of Regulation S restrictions from shares
20th May 20228:41 amRNSResignation of Chief Financial Officer
3rd May 20227:00 amRNSPosting of Annual Report & Notice of AGM
6th Apr 20221:36 pmRNSRemoval of Reg S restrictions from common stock
28th Mar 20227:00 amRNSGrant of Share Options
21st Mar 20227:00 amRNSResults twelve months ended 31 December 2021
24th Jan 20227:00 amRNSNew contract awards
21st Jan 20227:00 amRNSExercise of Options
6th Dec 20217:00 amRNSNew K-cup Orders in Q4 Exceed Expectations
2nd Nov 20213:37 pmRNSExercise of Options
25th Oct 20214:18 pmRNSRemoval of Regulation S restrictions
11th Oct 20217:00 amRNSLarge Central Bank Order
13th Sep 202110:27 amRNSHolding(s) in Company
25th Aug 202111:23 amRNSRemoval of Regulation S restrictions
21st Jul 20217:00 amRNSBanknote cleaning system also deactivates Covid-19

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.